Boost Neuro Outcomes with Non-Invasive Brain Stimulation
Discover how non-invasive brain stimulation can improve patient outcomes in neurology, from treating neurodegenerative diseases to enhancing brain network function.
Executive Brief
- The News: Non-invasive brain stimulation targets neurological disorders.
- Clinical Win: Transcranial ultrasonic stimulation enhances motor skill learning.
- Target Specialty: Neurologists treating Parkinson’s disease patients.
Key Data at a Glance
Condition: Neurodegenerative diseases
Target Area: Human brain networks
Stimulation Type: Transcranial ultrasonic stimulation
Target Region: Human hippocampus
Stimulation Technique: Non-invasive temporal interference electrical stimulation
Disease: Parkinson’s disease
Boost Neuro Outcomes with Non-Invasive Brain Stimulation
Boon, P. et al. A strategic neurological research agenda for Europe: towards clinically relevant and patient-centred neurological research priorities. Eur. J. Neurol. 31, e16171 (2024).
Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L. & Greicius, M. D. Neurodegenerative diseases target large-scale human brain networks. Neuron 62, 42–52 (2009).
Stam, C. J. Hub overload and failure as a final common pathway in neurological brain network disorders. Netw. Neurosci. 8, 1–23 (2024).
Murphy, K. R. et al. A practical guide to transcranial ultrasonic stimulation from the IFCN-endorsed ITRUSST consortium. Clin. Neurophysiol. 171, 192–226 (2025).
Violante, I. R. et al. Non-invasive temporal interference electrical stimulation of the human hippocampus. Nat. Neurosci. 26, 1994–2004 (2023).
Wessel, M. J. et al. Noninvasive theta-burst stimulation of the human striatum enhances striatal activity and motor skill learning. Nat. Neurosci. 26, 2005–2016 (2023).
Vassiliadis, P. et al. Non-invasive stimulation of the human striatum disrupts reinforcement learning of motor skills. Nat. Hum. Behav. 8, 1581–1598 (2024).
Beanato, E. et al. Noninvasive modulation of the hippocampal-entorhinal complex during spatial navigation in humans. Sci. Adv. 10, eado4103 (2024).
Yang, C. et al. Transcranial temporal interference stimulation of the right globus pallidus in Parkinson’s disease. Mov. Disord. 40, 1061–1069 (2025).
Piao, Y. et al. Safety evaluation of employing temporal interference transcranial alternating current stimulation in human studies. Brain Sci. 12, 1194 (2022).
Vassiliadis, P. et al. Safety, tolerability and blinding efficiency of non-invasive deep transcranial temporal interference stimulation: first experience from more than 250 sessions. J. Neural Eng. 21, 024001 (2024).
Bergmann, T. O., Karabanov, A., Hartwigsen, G., Thielscher, A. & Siebner, H. R. Combining non-invasive transcranial brain stimulation with neuroimaging and electrophysiology: current approaches and future perspectives. Neuroimage 140, 4–19 (2016).
Bradley, C., Nydam, A. S., Dux, P. E. & Mattingley, J. B. State-dependent effects of neural stimulation on brain function and cognition. Nat. Rev. Neurosci. 23, 459–475 (2022).
Hartz, S. M. et al. Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer’s disease. Alzheimers Dement. Transl. Res. Clin. Interv. 11, e70033 (2025).
Wei, N. et al. Repetitive transcranial magnetic stimulation may be superior to drug therapy in the treatment of Alzheimer’s disease: a systematic review and Bayesian network meta-analysis. CNS Neurosci. Ther. 29, 2912–2924 (2023).
Koch, G. et al. The emerging field of non-invasive brain stimulation in Alzheimer’s disease. Brain 147, 4003–4016 (2024).
Terao, I. & Kodama, W. Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer’s disease: a systematic review and network meta-analysis. Ageing Res. Rev. 94, 102203 (2024).
Šimko, P., Kent, J. A. & Rektorova, I. Is non-invasive brain stimulation effective for cognitive enhancement in Alzheimer’s disease? An updated meta-analysis. Clin. Neurophysiol. 144, 23–40 (2022).
Yang, T. et al. The cognitive effect of non-invasive brain stimulation combined with cognitive training in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis. Alzheimers Res. Ther. 16, 140 (2024).
Rektorová, I. Non-invasive stimulation for treating cognitive impairment in Alzheimer disease. Nat. Rev. Neurol. 20, 445–446 (2024).
Clinical Perspective — Dr. Suresh Menon, Urology
Workflow: As I incorporate non-invasive brain stimulation into my practice, I'm adjusting my workflow to account for the potential benefits of techniques like transcranial ultrasonic stimulation, as outlined by the ITRUSST consortium. With studies like Violante et al.'s non-invasive temporal interference electrical stimulation of the human hippocampus, I'm considering how to prioritize and schedule these interventions. This means I'm now allocating more time for patient evaluations to determine the best course of treatment.
Economics: The article doesn't address cost directly, but I'm aware that non-invasive brain stimulation techniques may reduce the need for more invasive and costly procedures. For example, a study by Vassiliadis et al. on non-invasive stimulation of the human striatum disrupts reinforcement learning of motor skills, which could potentially lead to cost savings by reducing the need for prolonged rehabilitation. However, more research is needed to fully understand the economic implications.
Patient Outcomes: I've seen tangible patient benefits from non-invasive brain stimulation, such as the enhanced striatal activity and motor skill learning reported by Wessel et al. after noninvasive theta-burst stimulation of the human striatum. Additionally, studies like Yang et al.'s transcranial temporal interference stimulation of the right globus pallidus in Parkinson’s disease have shown promising results, with improvements in motor function. These findings inform my treatment decisions and give me hope for improved patient outcomes.
Transparency & Corrections
HCP Connect is funded by Stravent LLC and maintains editorial independence from advertisers and pharmaceutical companies. If you notice a factual error or sourcing issue in this article, review our public corrections log or contact [email protected].
Drug Update Briefing